Autism Recovery Network
Autism Incidence Statistics & Epidemiology
US Department of Education Figures On Autism
Number and Change in Number of Children Ages 6-21 Served Under IDEA,
Part B
www.ideadata.org/tables/ar_aa2.htm
The Autism Explosion
Bernard Rimland, Ph.D.
Autism Research Institute
www.autism.com/ari/editorials/explosion.html
The Autism Autoimmunity Project
www.gti.net/truegrit/
*********************************************
December 14, 2001
Autism "No Longer A Rare Condition"
[By Emma Young.]
http://www.newscientist.com/news/news.jsp?id=ns99991687
A massive and co-ordinated research effort to identify the causes of
autism is urgently needed, say the authors of a major UK Medical
Research Council review of autism research.
The review concludes that autism and related disorders are far more
common than previously thought - and that there is no firm evidence to
date linking any environmental trigger with the disease.
Autism and related disorders affect six in every 1000 children aged
under eight, the team found. The previous figure accepted by the MRC was
between one and two per 1000. The increase is bound to altered ideas
about what constitutes an "autism spectrum disorder", as well as
increased awareness of the condition, the group says.
Their review of previous research revealed no evidence of a link between
the controversial MMR vaccine and autism. The group also found no firm
evidence linking immunological or bowel problems with the disorder -
links that have been suggested by some researchers.
"There have been some recent very high quality epidemiological studies
in the UK, but individually, these studies are quite small. We need
future research that is interdisciplinary and has the strength of being
population-based, so we're not studying biased samples of children,"
says Carol Dezateux, a consultant paediatrician at the Great Ormond
Street Hospital in London, and a member of the review group.
Nature vs nurture
Judith Barnard of the UK's National Autistic Society, who took part in
the review, says: "We're very pleased with this report, which has been
long overdue. It's an area that has been woefully under-researched in
the UK in the past. Most importantly for me, the report formally
recognises that autism can no longer be considered to be a rare
condition."
The group says it is increasingly clear that there is a genetic
component to autism. But long-term prospective studies of large numbers
of children, including genetic, as well as detailed health and lifestyle
data, will be needed to help tease apart the genetic and environmental
components of the disorder, says Dezateux.
Much more basic biological work, to investigate differences between
autistic and healthy brains, for example, is also necessary, she says.
Dedicated funding
How that research will be co-ordinated is another matter. The MRC
can boost "robust" inter-disciplinary autism research proposals by
targeting funds at these projects, Dezateux says.
But, says Barnard: "Two years ago, the MRC issued a report on autism and
bowel disorders and called for specific research. Nothing on that list
has yet been done, because they are waiting for 'robust' proposals." "We
are asking the Department of Health for a dedicated funding stream for
autism research," she says, "and raising the issue of a need for a
pro-active body to implement the findings of these review."
The review is published on the MRC's website: http://www.mrc.ac.uk/PDFs/autism_report.pdf
*********************************************
December 13, 2001
Autism 2001: The Silent Epidemic
F. Edward Yazbak, MD, FAAP.
Note: The information is not a substitute for diagnosis and
treatment by a qualified, licensed professional.
Although 2001 was filled with news of the MMR vaccine controversy,
discussion of the enormity of the autism explosion and its impact has
been minimal. In the UK, the Government spent more money and enormously
more time defending the MMR vaccine and destroying its critics than
actually researching the causes and the increasing incidence of autism.
The cruel reality is that the last published incidence of autism in the
UK of 1 in 324 (Journal of the American Academy of Child and Adolescent
Psychiatry, volume 39, p 694), was just amended this week to 1 in 166,
according to a Medical Research Council (MRC) report commissioned by the
Department of Health. A National Autistic Society survey had found that
1 in 110 children under 11 has autism.
The vaccine authorities still assert that the reported increase is
unrelated to the use of the MMR vaccine but offer no other reasonable
cause. The toll in human suffering is immense, and the actual financial
cost per child for a lifetime of care and support services is a
staggering 2 million plus British pounds.
Similar increases in the incidence of autism have been reported on the
European Continent. A Swedish study in 1993 by Ehlers and Gillberg found
a rate of 71 per 10,000 (1 in 141) in children with IQs of 70 or above.
A Finnish study looking at the incidence of autism in the northern
provinces, revealed a fourfold increase between 1979 and 1994 with a
present incidence rate of 1 in 483 among 5 to 7-year-olds (European
Child and Adolescent Psychiatry, volume 9, p 162). Also, in this study,
a clear increase in the number of children with IQ of 70+ was reported.
(This finding has often been reported with regressive or late-onset
autism.) Interestingly, this particular Finnish study went almost
unnoticed, while other Finnish studies (of dubious epidemiological
relevance) were highly publicized because they supported the MMR
vaccine's safety.
In the United States, the atrocities of September 11, the Anthrax
letters and the present war in Afghanistan have certainly touched every
one. But life goes on. For the parents of children with autism, each
day's battle is overwhelming and their lives have changed forever. There
is no final victory they can look forward to and no end to their war in
sight. Each morning brings new problems, new challenges and more
concerns about funding cuts and decreased services. Every night, the
same awful dream recurs “What will happen to my child when I am gone?
According to the Department of Education annual reports to the US
Congress, autism cases in children aged 6-21 in US schools increase
yearly by approximately 25.
Since September 12, it is more than likely that between 600 and 700 new
cases of autism were diagnosed and accepted into the system in
California alone. This projection is based on the last published 3-month
rate of between 7 and 8 new cases a day. If the average incidence of new
cases of autism in the remaining 49 states averages only 1/8th of the
California rate-- a very conservative estimate, indeed-- we should
expect that approximately 4000 new cases of autism have been diagnosed
nationwide in the last 3 months. In the United States, the cost per
child over a lifetime is soon to surpass 2 million dollars.
One can only imagine the outcry if there was an outbreak of 4000 cases
of any other pediatric illness in the same 3-month period. The CDC
specialists would be clamoring for a cure and seriously looking for
clues to the epidemic. Why aren't they?
We witnessed the reaction that followed 15 cases of anthrax on the East
Coast. Before anyone without personal experience with autism rushes to
criticize this statement, I respectfully submit that 10 out of the 15
cases of anthrax went on to complete recovery, a result we will never
have with autism. As for the five deaths from anthrax, they are
certainly sad and most unfortunate but children with severe autism have
brain damage, and die every day even if they are still breathing and
moving. Every day, their parents and grand parents die a little too.
Research into the causes of autism is being carried out nationwide. Many
studies dealing with biochemical and genetic causes are published and
only receive transient interest. It is likely that many studies
concerning genetics now in progress will go similarly unnoticed, as it
is impossible to have an epidemic of genetic diseases.
The impressive mercury study undertaken by a group of dedicated parents
in New Jersey is different. It deserves our attention and gratitude, and
supports the original Redwood theory of mercury damage. It now appears
that the CDC also carried out a study, which suggested some relationship
between mercury in vaccines and neuro-developmental disorders in
infants.
A special committee of the Institute of Medicine (IOM) held hearings on
the subject of mercury and autism, and recommended removing thiomerosal
from all pediatric vaccine formulations. The American Academy of
Pediatrics (AAP) and the CDC had also recommended an all mercury-free
vaccine schedule. All three organizations believe that
mercury-containing vaccines have not actually caused damage to children.
Concern over mercury has attracted the attention of the manufacturers of
adult vaccines. On November 21, the FDA announced that a single-dose
influenza vaccine for adult use, with only a trace of thiomerosal, is
now available.
Our own research seems to indicate that, certain children have reacted
unfavorably and were "set-up" by mercury-containing vaccines in year one
and then have regressed into autism following another antigenic insult
in their second year of life.
The auto-immune theory of autism and the possible relationship between
autism and MMR vaccination have captivated many minds since they were
formulated in 1998. Although no one has proved conclusively that MMR
vaccination has contributed to the increase in autism in the western
world, no one has convincingly proved that it has not.
While the vaccine lobby and authorities have adamantly and viciously
condemned Andrew Wakefield and his findings, hundreds of parents are
totally convinced he is right. These parents have no doubt that their
previously normal children became symptomatic after their first MMR
vaccination and then regressed into autism, and many have videos,
pictures and doctors' notes to prove it. A further regression after the
second MMR, at age 5, seems to have convinced some of those parents even
more.
The identification of measles by intricate PCR testing in the British
pathological specimens and the later revelation that these measles
strains were of vaccine origin, by independent Japanese researchers, do
offer more support to the hypothesis. The likelihood that any
investigator would try duplicating these findings after witnessing Dr.
Wakefield's public lynching is remote.
In London, many children with autism have been investigated carefully
and found to have abnormal pathology in the colon, the terminal ileum
and the esophagus. A group of children in the US have also been found to
have identical pathological findings.
In March 2001, an IOM committee looking at autism and MMR, reported
that, "evidence favors rejection of a causal relationship at the
population level between MMR vaccine and autistic spectrum disorders. A
little later in the report, the committee conceded that it could not
exclude the possibility that MMR vaccine could contribute to ASD in a
small number of children". and went on to recommend further research on
the subject.
The media propaganda asserted that the committee took the MMR "off the
hook" but failed to highlight the similarity between the committee's
conclusions and Wakefield's own: that the MMR vaccine could contribute
to autism in a small group of genetically predisposed children, and that
good research is urgently needed.
The IOM report on MMR and autism was published on April 24, 2001 (www.iom.edu,
recent reports) The Institute of Medicine (IOM) Committees' conclusions,
which are strictly based on epidemiological data, require a large number
of cases to justify one of the following classifications.
No evidence bearing on a causal relation.
The evidence is inadequate to accept or reject a causal relation.
The evidence favors rejection of a causal relation.
The evidence favors acceptance of a causal relation.
The evidence establishes a causal relation.
It is well known that it takes years and mountains of epidemiological
evidence, for the IOM committees to even consider a complication, and/or
move it from a certain category to a higher one.
[The perfect example is in the report published on 4/23/2001 ONE day
before the MMR report in question. It concerns Agent Orange. In 1991,
the Veterans Administration commissioned a study on the defoliant and
appropriated a million dollars towards that research. There have been
many reports from the IOM committees on the subject and many revisions.
It is only in April 2001-- a full TEN years into the study-- that
Diabetes Mellitus and Children's Myelogenous Leukemia were moved from
Category 3, where they had previously been listed, to Category 4.
Clearly these two complications had been caused by Agent Orange exposure
since the Vietnam War; hundreds of veterans and many VA physicians never
doubted that Agent Orange caused them. The fact that it took the IOM
committee so long to concur did not alter that reality.
At its first meeting on the subject, the IOM committee actually placed
the MMR-Autism problem in category 3+ by adding that a few cases of
autism did follow MMR vaccination. Many issues never make it past class
1 or 2 this early on.
It is likely that the matter will be reviewed again in the not so
distant future, because of the continued attention generated by the
debate, and the justified criticisms which surrounded the release of the
first report.
It is tragic that while all this discussion about administering three
live viruses at the same time is going on, the authorities in both the
US and the UK have decided to add the chicken pox vaccine to the present
MMR formulation. Not too long ago, health care providers had to wait a
month between the administration of MMR and the chicken pox vaccine. Now
they are assured that giving them together in the same syringe does not
affect their safety and efficacy.
Other vaccines to treat less serious illnesses are being developed at a
frantic pace and will be certainly added to the present "routine"
schedule. Mega-combinations are promised and well known infectious
disease specialists and immunologists have no difficulty stating that a
child's immune system can comfortably deal with all these simultaneous
antigenic assaults, even if he is very young, febrile, and on
antibiotics.
Empathic and qualified pediatricians and pediatric nurse practitioners
are urgently needed to control the present autism epidemic. A high index
of suspicion, an early work up, and a firm diagnosis are imperative to
assure timely initiation of therapy and limitation of brain damage.
The children must never be referred to as "autistic" because they do not
have a psychiatric illness. They suffer from autism, a multi-system
medical illness, with neurological, gastro-intestinal, endocrine,
immune, developmental, communicative, and psychiatric issues. Each of
them needs a pediatric expert who can care for the whole patient and who
has liberal access to consultants.
Sensible and affordable therapy should be available to each and every
affected child. Parents need not uproot and move to find good medical
care and superior schools.
Serious independent research is urgently needed. It can not be expected
from people with agendas of their own, or questionable financial ties.
It also can not be performed on computers looking at epidemiological
data. It must include parents' interviews and a careful examination of
the affected child.
It is only then that there will be any hope to control this silent and
most tragic pediatric epidemic of our time. Regressive autism should
have never happened!
The above is my personal opinion and may not reflect that of
organizations to which I belong.
F. Edward Yazbak, MD, FAAP
December 13, 2001
TLAutStudy@aol.com
*********************************************
Prevalance of Autism in Metropolitan Atlanta in 1996
M. Yeargin-Allsopp et al. National Center on Birth Defects and
Developmental Disabilities, CDC, Atlanta, GA
***N = 290,000***
The prevalance rate of autism and the possible increase in numbers of
people with autism is highly debated among professionals and parents.
Epidemiologic studies outside of the United States before 1985 report
rates of 4-5 per 10,000 children for the autism spectrum disorders and
approximately 2 per 10,000 for autistic disorder. More recent studies
indicate a mean autistic disorder prevalance of approximately 1 per
1,000 children and a prevalance of approximately 2 per 1,000 children
with autism spectrum disorders. Within the United States, the few
studies that exist indicate low prevalance rates, i.e., approximately 4
per 10,000 children. However, one recent US study reported rates of 4.0
children per 1,000 with autism and 6.7 per 1,000 with autism spectrum
disorders [Brick Township, NJ]. Recent data from the California
Department of Developmental Services and the United States Department of
Education also indicate large increases in the number of children with
the autism spectrum disorders identified for services. Changing
diagnostic criteria and examination of different populations using
different methods make comparing rates and changes across sites and over
time difficult.
A study by the Centers for Disease Control and Prevention determined the
prevalance of autism using a population-based methodology in 5 counties
of metropolitan Atlanta for children ages 3-10 years in 1996 (N =
290,000). Children with autism were identified through a systematic
review of evaluation records at multiple sources, e.g., schools,
clinics, evaluation centers. A panel of clinicians and researchers
developed a systematic coding scheme that was applied to each individual
record according to the Diagnostic and Statistical Manual of Mental
Disorders IV (DMS-IV) criteria for autistic disorder. Results indicate
thatthe rate for autism in the metro Atlanta area was 3.4 per 1,000 in
1996 for children aged 3-10 years. Additional demographic factors of the
Atlanta population of children with autism will also be presented. These
data suggest that the rate of autism is considerably higher that
previously thought. Reasons for the higher rate will be discussed.
*********************************************
From the desk of Rick Rollens:
January 16, 2002
With no changes in the diagnostic criteria for many years, and in a
system that has been ascertaining autism since 1970, the California
Department of Developmental Services (DDS) recently released the
following data on the number of new cases of fully diagnosed DSM IV
(Level One) AUTISM (NOT including other autism spectrum disorder such as
PDD, NOS, or Asperger's, or other rare "autism like" genetic diseases):
1. An all time one year (1970-2001) record number of cases (2,725) were
added to California's system in 2001. This number represents a 20%
increase in one year over the previous record year of 2000. The just
completed 4th Quarter of 2001 (Oct. 4, 2001 to Jan. 3, 2002) also set an
all time record for numbers of new cases for any 4th Quarter in the
history of the system. During 2001, each of the four quarters posted all
time record setting increases. THERE WERE MORE CASES OF LEVEL ONE AUTISM
ADDED IN 2001 THEN IN ALL OF 1994, 1995, AND 1996 COMBINED.
2. In 2001, for the first time ever in California's history, level one
autism became the number one disability entering California's
system...accounting for an astonishing 35% of all new intakes in 2001. A
percentage that has exploded from historic levels of 3%. AUTISM HAS
SURPASSED MENTAL RETARDATION, CEREBRAL PALSY, EPILEPSY, AND ALL OTHER
CONDITIONS SIMILAR TO MENTAL RETARDATION AS THE NUMBER ONE DISABILITY
ENTERING CALIFORNIA'S DEVELOPMENTAL SERVICES SYSTEM.
3. California now has 16, 802 persons with level one autism in it's
system. IT TOOK 25 YEARS (1970-1995) TO ADD 6,527 CASES. UNBELIEVABLY,
IT HAS TAKEN ONLY 3 YEARS (1999-2001) TO ADD AN ADDITIONAL 6,596 NEW
CASES. SIMPLY PUT, WHAT USE TO TAKE 25 YEARS NOW TAKES THREE.
4. According to DDS, of the 16,802 persons with level one autism in it's
system: 82% are male, 56% have NO mental retardation, and 80% were born
after1980... the beginning of the autism epidemic. AMAZINGLY, OF THE
TOTAL NUMBER OF PERSONS IN THE SYSTEM (16,802).... 11,104 OR TWO OUT OF
EVERY THREE PERSONS (66%) ARE CHILDREN BETWEEN THE AGE 0 TO 13 YEARS
OLD.
*********************************************
PRESS RELEASE October 17, 2001
Press release re internal CDC report on thimerosal and autism
An announcement was made today by the law firm of Waters & Kraus, the
firm that filed the first known lawsuit alleging that a mercury
preservative in children's vaccines caused neurological damage to an
infant ultimately diagnosed with autism. Waters & Kraus is leading a
consortium of ten firms in as many states that are actively prosecuting
cases of this nature (firms listed below). Andy Waters, the lead
attorney in the cases, announced that his firm is now in possession of a
previously unreleased confidential report authored by Centers for
Disease Control scientists which studied autism as a potential
neurological injury caused by mercury in children's vaccines.
A different version of the report was made public and has been cited by
the recent Institute of Medicine study as inconclusive on the issue of
whether the mercury-based vaccine preservative known as thimerosal has
contributed to cause a nationwide epidemic of regressive autism and
other neurological disorders in small children. The confidential version
of the study, however, clearly demonstrated that an exposure to more
than 62.5 micrograms of mercury within the first three months of life
significantly increased a child's risk of developing autism.
Specifically, the study found a 2.48 times increased risk of autism -
that is to say, children with the exposure were more than twice as
likely to develop autism as children not exposed.
In the United States, courts of law have generally held that a relative
increased risk of 2.0 or higher is sufficient to substantiate that a
given exposure causes disease. As but one example, in the case of Cook
v. United States, 545 F.Supp. 306, at 308 (Northern District -
California 1982) the Court stated that, "in a vaccine case, a relative
risk greater than 2.0 establishes that there is a greater than 50%
chance that the injury was caused by the vaccine."
Waters indicated that, in many of the cases his firm has evaluated,
including the case filed in a Texas state court on behalf of the Counter
family, the affected child received more than 62.5 micrograms of mercury
through pediatric vaccines in the first three months of life.
The confidential report, which was obtained by the SAFEMINDS support and
advocacy group, states: "As for the exposure evaluated at 3 months of
age, we found increasing risks of 'neurological developmental disorders'
with increasing cumulative exposure to thimerosal ... within the group
of 'developmental disorders'... for the sub-group called 'specific
delays,' and within this sub-group for the specific disorder
'developmental speech disorder,' and for 'autism,' 'stuttering' and
'attention deficit disorder.'"
The report also contained the graph depicted below which illustrated the
report's findings of a child's increasing risk of developing the
neurological symptoms of autism after receiving increasing amounts of
thimerosal.
Graph 3: Relative risk - 95 % CI of Autism after different exposure
levels of thimerosal at 3 months of age, NCK & GHC (see
www.vaccineinfo.net/autismHg.htm to view graph)
Waters pointed out that the confidential study's lead author, Thomas
Verstraeten, has since left the Centers for Disease Control and is now
employed by GlaxoSmithKline, a manufacturer of thimerosal-containing
vaccines for many years that is a defendant in numerous suits pending
nationwide. "We have asked GlaxoSmithKline to provide Mr. Verstraeten's
deposition in order to understand if conflict of interest issues may
have played a role in the CDC's decision to keep this report
confidential, and specifically, their failure to reveal it to the
Institute of Medicine."
Waters called the report's contents and the fact that it was kept from
the public as "shocking, but unfortunately not surprising, given the
political influence of pharmaceutical companies and the tremendous
liability they face if they are forced to compensate thousands of
families for the costs of care that these children require." Waters
added that "no amount of money can give these children back the
potential that they were born with, and no amount of money will comfort
the parents that watched helplessly as their children literally just
slipped away." The purpose of the lawsuits his firm is currently
prosecuting, said Waters, is "to bring to the surface the truth on this
issue, a truth that government agencies seem unwilling to admit, perhaps
for fear that parents will stop vaccinating their children, and to force
the companies that profited from this disastrous mistake to shoulder the
responsibility that so many families now bear on their own, often
without even the aid of health insurance benefits."
Media inquiries should be directed to Melissa Miles at 214-357-6244.
Client inquiries should be directed to Victoria Gibson at 800-226-9880,
or to the firms listed below.
Other firms working with Waters & Kraus to prosecute individual cases
involving thimerosal exposure are:
ANDERSON & KRIEGER, APLC
40925 County Center Drive, Suite 210
Temecula, California 92591
Telephone: 909-296-5090
DOGAN & WILKINSON
726 Delmas Avenue
Pascagoula, Mississippi 39567
Telephone: 228-762-2272
DORAN & MURPHY, LLP
1234 Delaware Avenue
Buffalo, New York 14209
Telephone: 716-884-2000
EVERT & WEATHERSBY, L.L.C.
3405 Piedmont Road, Suite 225
Atlanta, Georgia 30305-1764
Telephone : 404-233-8718
HENDRICKSON & LONG
214 Capital Street
P.O. Box 11070
Charleston, W. VA 25339
Telephone: 304-346-5500
JONES, MARTIN, PARRIS, & TESSENER LAW OFFICES, PLLC
410 Glenwood Ave., Suite 200
Raleigh, North Carolina 27603
Telephone: 919-821-0005
LEACH, SCHWARZ & STRASSBERG
11 Bala Ave.
Bala Cynwyd, Pennsylvania 19004
Telephone: 610-668-7964
MARTZELL & BICKFORD
338 Lafayette Street
New Orleans, Louisianna 70130
Telephone: 504-581-9065
WISE & JULIAN, PC
3555 College Avenue
Alton, Illinois 62002
Telephone: 618-462-2600
*********************************************
Studies Fail To Disprove Autism Link To MMR Jab
[By Lorraine Fraser in today's Sunday London Times.]
http://www.portal.telegraph.co.uk/news/main.jhtml?xml=%2Fnews%2F2001%2F12%2F09%2Fnjab09.xml
<-- address ends here.
A report commissioned by the [British] Government has concluded that the
possibility of MMR vaccination causing autism in susceptible children
cannot be ruled out on the current evidence.
The review, from the Medical Research Council, will say the theory that
the triple measles, mumps and rubella jab is to blame in some autistic
children has not been proved scientifically.
However, it will add that epidemiological studies so far of MMR have
been too imprecise to rule out the prospect of the vaccination being
involved in a small number of cases.
The findings, to be made public next week, will create difficulties for
Alan Milburn, the Health Secretary, who asked the MRC last March to look
at all available evidence on the causes of autism and identify any gaps
in present knowledge.
His officials at the Department of Health have heavily publicised
studies that failed to link MMR and autism in their attempts to convince
parents there is no risk.
The MRC's report comes after The Telegraph revealed how the doctor who
first voiced fears about the safety of MMR, Dr Andrew Wakefield, has
been forced out of his job at the Royal Free and University College
Medical School in London.
Dr Wakefield claims to have identified nearly 200 children with a new
combination of bowel disease and autism and has pledged to continue his
efforts to find out whether their double illness has been triggered by
the childhood injection. He disclosed last weekend that his university
employers had asked him to leave because his research was unwelcome.
The Department of Health insists parents have no need for concern over
the safety of MMR (recommended for babies and four-year-olds) and
officials have accused Dr Wakefield of needlessly damaging parents'
confidence in the vaccination, leaving children at risk of the
illnesses.
However, the report of the MRC Review Group, headed by Eve Johnstone,
professor of psychiatry at the University of Edinburgh, will raise new
questions as to why the doctor has been ostracised by the medical
establishment.
While it offers no support for Dr Wakefield's theory that measles virus
from the MMR vaccine may colonise the gut of susceptible children and
cause bowel effects which result in a chemical imbalance, leading to
autism, The Telegraph understands the report will nevertheless make
clear that more research is needed before the hypothesis can be either
confirmed or refuted.
The document, which has been sent to the Department of Health prior to
publication, is expected to argue that the cause of autism may differ
between individuals, and future research must try to take account of
factors such as genetics, environmental exposures before and after
birth, infections, and the development of the child's immune system.
In particular, it will take issue with a Finnish study of three million
children which has been widely reported as proof that MMR does not cause
bowel disease or autism.
The MRC conclusions agree with a report from the Institute of Medicine
in the US, which backed the use of MMR but also said research so far
could not exclude the possibility that MMR may be damaging some
youngsters.
Dr Timothy Buie, a specialist at Harvard General Hospital, has also
announced that he found inflammation of the bowel identical to that
described by Dr Wakefield in 15 of 89 autistic children seen at his
Massachusetts clinic.
He said: "These children are ill, in distress and pain, and not just
mentally, neurologically, dysfunctional."
Dr Wakefield's departure from the Royal Free Hospital has devastated
parents of children involved in his studies, who are demanding
assurances that their youngsters will continue to be looked after by the
north London hospital.
Dr Wakefield agreed to stand down after a two-year struggle to stay in
his post, hoping that this would relieve the "political pressure" on
clinical colleagues responsible for day-to-day care of the sick
children.
Paediatric gastroenterologists at the Hampstead hospital have developed
considerable expertise in relieving the children's bowel pain and
related symptoms, but some sick children are having to wait up to 18
months to be seen.
Last week angry families established a lobby group, Autism Research
Campaign for Health (ARCH), to push for greater recognition of their
children's problems.
*********************************************
Harvard Clinic Scientist Finds Gut/Autism Link, Like Wakefield
Findings
Dr. Timothy Buie, a pediatric gastroenterologist from Harvard/Mass
General Hospital has performed over 400 gastrointestinal endoscopies
with biopsies, as well as evaluation of digestive enzyme function in
children diagnosed with autism and finding a connection. The results of
his testing are similar to the observations made by Dr. Andrew Wakefield
regarding the presence of chronic inflammation of the intestinal tract,
although the incidence was noted to be less frequent in his group.
Dr. Buie announced his findings last Saturday at the Oasis 2001
Conference for Autism in Portland, Oregon, the day before the
announcement of Wakefield's forced departure from Royal Free in the UK.
The biopsy results indicated the presence of chronic inflammation of the
digestive tract including esophagitis, gastritis and enterocolitis along
with the presence of Iymphoid nodular hyperplasia in 15 of 89 children.
Additionally the results of the enzyme testing of Dr. Buie's patients
paralleled that of Dr. Karoly Horvath and colleagues at the University
of Maryland School of Medicine. Dr. Buie found that the autistic
children he examined showed disaccbaride/glucoamylase enzyme levels
below normal. Some 55% of these children had lactase deficiencies (which
breaks down lactose in milk) as well as deficiencies of the enzyme
sucrase (responsible for digestion of table sugar).
The findings also lend support to anecdotal reports of improvement of
some autistic children on wheat and dairy (gluten, casein) free diets.
Buie says that Harvard wants to do research into the use of protein
enzyme supplements, which aid in the digestion of wheat and milk
products for treatment.
Buie echoed the opinion of other a growing number of clinical
researchers and practitioners treating autistic patients, "these
children are ill, in distress and pain, and not just mentally,
neurologically dysfunctional."
*********************************************
http://www.gastrohep.com/freespeech/freespeech.asp?id=72#comments
Measles-containing vaccines and IBD.
Andrew Wakefield, 02 January 2002
In an ironic twist, investigators from the Centers for Disease
Control and Prevention (CDC) and the Vaccine Safety Datalink (VSD)
Project have confirmed an association between measles-containing
vaccines (MCV) and inflammatory bowel disease. Specifically, they have
also determined how age at exposure to an MCV may be important in
determining the type of inflammatory bowel disease - Crohn's disease or
ulcerative colitis - that develops [1].
Before the American Society of Microbiology's millennium meeting, Davis
et al. reported a retrospective case-control study in which cases (n =
142) with either Crohn's disease, or ulcerative colitis, were compared
with unaffected controls (n = 432). The exposure of interest was to an
MCV.
When performing the power calculations to determine the necessary size
of the study, Davis et al. assumed an MCV-exposure rate of 70%. In
actual fact, the exposure rate was 93-94%, revealing a fundamental flaw
in the study - overmatching.
Exposure of cases and controls to an MCV was so similar that their
study, as designed, would never have detected a risk for inflammatory
bowel disease, even if this risk were real.
Although these crucial data were presented to the American Society for
Microbiology (at the Interscience Conference on Antimicrobial Agents and
Chemotherapy in November 2000), they received no comment in the
subsequent paper published in Arch Pediatr Adolsce Med. An explanation
is clearly required.
In order to determine whether exposure to an MCV is or is not a risk for
inflammatory bowel disease, at the level identified previously [2],
power calculations reveal that they would have required at least 3 times
as many cases and controls as were included in the study.
The correct power calculations were readily performed using the Epi.Info
package, downloaded from the CDC website.
Age at exposure and risk
In a recent Israeli study, exposure to measles virus was shown to be
associated with an increased risk for Crohn's disease [3]. In addition,
measles virus (including vaccine-strain virus) has been amplified and
sequenced from intestinal tissues of children with inflammatory bowel
disease [4]. However, in the etiology of inflammatory bowel disease, it
is likely that it is the pattern of exposure to measles that is more
important than exposure per se.
Of interest in the Davis study, therefore, was the observation of an
association between age at exposure to an MCV (excluding MMR) and the
type of inflammatory bowel disease that develops [1]. This observation
is entirely consistent with previously reported data, and supports a
role for atypical measles virus infection in the etiology of
inflammatory bowel disease. Such a claim should not be made lightly, and
therefore it is worth reviewing the background to this thesis, that has
been described in detail elsewhere [5]-[7].
Age at exposure to natural measles infection is an important determinant
of both acute and delayed outcome.
Early measles infection has been reported as a risk factor for delayed
disease, including subacute sclerosing panencephalitis (SSPE) and IBD
[8]-[10]. For IBD, however, the situation is more complex still; the
risk associated with measles virus includes, for example, concurrent
exposure to measles and mumps infections in childhood [7] [11].
Studies have used the UK's birth cohort data (British Birth Cohort study
1970 [BCS 70] and the National Child Development Study [NCDS]), two
population-based, nationally representative, and powerful
epidemiological instruments. These have shown that, within an early
window of risk (measles exposure < 6 years of age) [5], other
characteristics of the acute measles exposure determine both the risk
and phenotype of IBD that develops.
Younger age at infection (high birth order, e.g. two or more older
siblings) (Fig 1) and younger age at exposure to concurrent measles and
mumps infection (Fig. 2) are a risk for ulcerative colitis.
Within this early window of risk, older age at infection (low birth
order, e.g. no older siblings) (Fig. 1) is associated with an increased
risk of Crohn's disease. Higher mean age at concurrent measles and mumps
exposure (Fig. 2), and higher age at monovalent measles vaccination
(Fig. 3) are also associated with an increased risk of Crohn's [12][13].
Fig 1
Fig 2
Fig 3
In the BCS 70 cohort, the age of concurrent measles and mumps infection
appeared to determine the risk of whether Crohn's disease or ulcerative
colitis developed in an individual. For Crohn's disease, the mean age of
exposure was greater than for ulcerative colitis. This difference was
statistically significant (p = 0.038).
Fig 4
Data for the birth order/family structure versus risk of Crohn's disease
or ulcerative colitis were then examined to see if this influenced the
age of concurrent measles/mumps infection, as predicted by our
hypothesis. This states that those with no older siblings (low birth
order) should experience concurrent infections later, whereas those with
two or more older siblings (high birth order) should experience the
concurrent infection earlier.
The data shown above in Figure 4 indicate that the differential risk for
concurrent infection according to number of older siblings is
statistically significant (p<0.001). Data are adjusted for sex and
socio-economic status.
The next question that we addressed was the issue of whether age of
exposure to monovalent measles vaccine (the only measles vaccine
available in the 1970s in the UK) influenced the risk of IBD in the BCS
70 cohort.
The hypothesis predicted that older age at measles vaccination, within
the early window of exposure (0-6 years), would be a risk for Crohn's
disease. This is indicated by the data shown in Figure 5.
Fig 5
In this cohort, age at exposure to monovalent measles vaccine, including
and excluding those with concurrent measles and mumps infections,
appears to be associated with risk of Crohn's disease. This was when
adjusted for sex, social class of father at birth, and crowding.
Children exposed the vaccine at an older age are at greater risk (p for
trend = 0.017). This is consistent with the fact the response to the
vaccine virus is a function of age and, possibly, influences of maternal
immunity.
The numbers of cases are small, and therefore independent corroboration
was required. This was provided by the Davis study, as shown below.
Fig 6
The Davis study identifies that those exposed to an MCV (excluding MMR)
at a younger age (< 12 months) appear to be protected against Crohn's
disease, but at excess risk of ulcerative colitis. Conversely, older age
at exposure is a risk for Crohn's disease, but protective against
ulcerative colitis. This is exactly as predicted by the previous data
and the a priori hypothesis.
Analysis of the raw data is required in order to establish whether or
not these trends are statistically significant.
The effects of the characteristics of the exposure are likely to reflect
age- and dose-dependent influences upon immune responses to the virus
that are consistent with models of immunological tolerance, as proposed
previously [5]-[7].
The study of Davis et al. provides valuable independent confirmation of
a possible association between age at measles exposure and the type of
IBD that develops.
What needs to be explained, beyond these observations, is the current
upsurge of IBD in children, including Crohn's disease, ulcerative
colitis, and the recently described autistic enterocolitis.
Questions arising:
Were the power calculations for the study, as reported [1], based upon
an assumed MCV exposure of 70% in cases and controls, as presented in
the original data set?
If the answer is 'no', please would Davis et al. provide the revised
assumptions and power calculations.
If the answer is 'yes', then having performed power calculations for the
size of the study based upon an estimated vaccine uptake of 70%, and
subsequently finding an actual uptake of 93-94%, what steps, if any,
were taken to reconcile this discrepancy prior to proceeding with the
study?
Why were the power calculations, as presented to the American Society
for Microbiology, not presented in the paper?
If the answer to question 1 is 'yes', and if no steps were taken to
reconcile the discrepancy, why was this not described in the paper as
published?
If the answer to question 1 is 'yes', then, based upon the obvious flaw
of overmatching, do the authors still consider the conclusions to be
valid?
References
Davis RL, Kramarz P, Bohlke K et al.. Measles-mumps-rubella and other
measles containing vaccines do not increase the risk for inflammatory
bowel disease: a case-control study from the Vaccine Safety Datalink
Project. Arch Pediatr Adolsce Med 2001; 155: 354-9.
Thompson N, Montgomery SM, Pounder RE, Wakefield AJ. Is measles
vaccination a risk factor for inflammatory bowel disease. Lancet 1995;
345: 1071-4.
Lavy A, Brodie E, Reif S et al.. Measles is more prevalent in Crohn's
disease patients. A multicentre Israeli study.Dig Liver Dis 2001; 33:
472-6.
Halsey NA, Hyman SL. Measles-mumps-rubella vaccine and autistic spectrum
disorder. Pediatrics 2001; 107: 1-23.
Wakefield AJ, Montgomery SM, Pounder RE. Crohn's disease: the case for
measles virus. Ital J Gastroenterol 1999; 31: 247-54.
Wakefield AJ, Montgomery SM. Measles virus and inflammatory bowel
disease: an unusually tolerant approach. Am J Gastroenterol 2000; 95:
3-5.
Montgomery SM, Morris DL, Pounder RE. et al.. Paramyxovirus infections
in childhood and subsequent inflammatory bowel disease.Gastroenterol
1999; 116: 796-803.
Ekbom A, Adami HO, Helmick CG, Jonzon A., Zack MM. Perinatal risk
factors for inflammatory bowel disease: a case-control study. Am J
Epidemiol 1990; 132: 1111-19.
Ekbom A, Wakefield AJ, Zack M, Adami HO. Perinatal measles infection and
subsequent Crohn's disease. Lancet 1994; 344: 508-10.
Pardi DS, Tremaine WJ, Sandborn WJ et al.. Early measles virus infection
is associated with the development of inflammatory bowel disease. Am J
Gastroenterol 2000; 95: 1480-5.
Montgomery SM, Bjornsson S, Johannsson JH, et al.. Concurrent measles
and mumps epidemics in Iceland are a risk factor for later inflammatory
bowel disease. Gut, 1998; 42: A41.
Montgomery SM, Pounder RE, Wakefield AJ. Age of older siblings and
inflammatory bowel disease. Gut 1999; 44: A29.
Montgomery SM, Twamley SI, Morris DL, et al.. Birth order influences IBD
risk and phenotype. Gut 1999; 44: A29.
http://www.gastrohep.com/freespeech/freespeech.asp?id=72#comments
*********************************************
Silent Epidemic: Autism
BR doctor blames immunizations for dramatic increase in autism cases
By TED GRIGGS
Advocate features writer
Advocate staff photo by Patrick Dennis Shelley Reynolds, left, and
Jeana Smith head Unlocking Autism, an organization dedicated to raising
awareness about the disability.
Shelley Reynolds' son Liam was perfectly normal from birth. He rolled
over, he crawled, he walked, he talked, all on schedule. At 13 months,
Liam learned the "Hokey Pokey." He knew the words to "The Itsy Bitsy
Spider."
Every morning on the way to daycare, he and Shelley sang "Old MacDonald
Had A Farm." Liam's part was the animal sounds. At daycare, he
practically lived in the sandbox.
And then virtually overnight, Liam's personality changed. He stoppd
making eye contact. His words twisted and turned around on themselves.
When he tried to say "fish" it came out "sheee."
Liam stopped singing. He stopped talking. He stopped sleeping. The touch
of certain fabrics or textures tormented him. He ripped off his clothes
as soon as his parents dressed him.
When the Reynolds took him to the beach that summer, Liam screamed
bloody murder every time his feet touched the sand.
Eventually, Liam was diagnosed with autism. It's a life sentence. There
is no cure.
Now Shelley Reynolds, like thousands of other moms with autistic
children, lives with a nauseating possibility: that the shots Liam got,
the regularly scheduled vaccinations designed to protect his health, may
have caused his disability.
Reynolds is one of many who believe childhood vaccinations and autism
spectrum disorder are linked. Jeana Smith of Walker is another. Smith
has identical twin sons. One is autistic.
"Everybody thinks that if they ignore it, somehow it's going to go away,
or this is going to stop happening, and that is simply not the case,"
Smith said.
The numbers of autistic children are rising. U.S. Department of
Education records show the number of autistic students increased
nationwide by more than 11,000 from the 1998-99 to the 1999-2000 school
year. A similar increase was reported between 1997-98 to 1998-99. Recent
studies in New Jersey and Sweden showed prevalence rates for autism
spectrum disorder as high as 1 in 150 to 170 children.
"There's enough people for this to be a national emergency," Smith said.
And it's going to be expensive. Education costs for autistic children
can run $40,000 a year or more.
For now, the vaccine-autism link remains a controversial and
scientifically unproved theory. And the Baton Rouge area continues to be
the home of some of the theory's fiercest defenders. Pediatrician
Stephanie Cave's success in treating autistic children is probably the
reason.
Her clinic cares for more than 1,000 autistic children. Parents swear by
her treatment plan, which removes toxic metals from her patients and
balances their body chemistry.
Smith and Reynolds credit Cave's treatment regimen for their sons'
recovery.
Cave has written a book that lays out some of the possible connections
between childhood immunizations and increased rates of autism, asthma,
diabetes and learning disabilities. In What Your Doctor May Not Be
Telling You About Children's Vaccinations, Cave attempts to answer
parents' questions about vaccine safety and immunization schedules. The
book also spells out steps families can take to ensure their children's
safety.
Cave and others say the rise in autism coincided with an increase in the
number of required childhood vaccines. The recommended childhood
immunizations tripled in the 1980s and '90s. Many of the vaccines
contained high levels of mercury.
The premise's backers believe it's no coincidence that behaviors common
among autistic children closely resemble the symptoms of mercury
poisoning.
The theory goes something like this:
Until recently, many childhood vaccines contained thimerosal, a
preservative that's 50 percent mercury. Mercury is highly toxic. An
infant less than 4-6 months old can't get rid of it. The poison builds
up in his body, unleashing a host of complications.
Mercury lodges in, and damages, the exact areas of the brain affected by
autism: the cerebellum, amygdala and hippocampus. These areas affect
coordination, emotions and memory.
Mercury also alters a child's immune and digestive systems. In these
children's damaged bodies, something as simple as an ice cream cone or a
bowl of spaghetti can produce the same effect another person would get
by injecting morphine.
Some researchers also believe that injecting the measles-mumps-rubella
vaccine into a child with a weakened immune system causes more digestive
problems, and may even trigger autism.
An alternative, scientifically proven view
Health care's heaviest hitters -- the Centers for Disease Control
and Prevention, the National Institutes of Health, the Institute of
Medicine, the Food and Drug Administration, the American Academy of
Pediatrics, the American Academy of Family Physicians, and
pharmaceutical manufacturers -- disagree.
All say the same thing: Vaccines are safe.
And public health agencies continue to support this view.
Last month, the Institute of Medicine's Immunization Safety Review
Committee concluded that the current evidence neither proves nor
disproves a link between thimerosal and autism spectrum disorder.
However, the committee also concluded that the hypothesis that mercury
in vaccines may be related to autism is "biologically plausible." And
the committee recommended the use of thimerosal-free DTaP, hepatitis B
and Hib vaccines, despite the fact that supplies of
thimerosal-containing vaccines are still available.
Backers of the vaccine-autism link see this as a crack in the
bureaucratic dam. They say the vaccine committee report strengthens
their position.
But Committee chair Dr. Marie McCormick said the recommendation follows
an established public health policy to reduce cumulative mercury
exposures.
There is no proof that the thimerosal in vaccines is dangerous,
McCormick said. If thimerosal-free vaccines are not available,
thimerosal-containing vaccines should be used.
The idea that thimerosal may be linked to autism is "very, very
hypothetical" at best, and some basic assumptions of the theory appear
flawed, McCormick said.
The vaccine-autism model assumes that an infant doesn't metabolize any
mercury for six months, McCormick said. "That's hard to believe."
One of the standard texts in neonatology states that bile secretion,
which helps metabolize most mercury, begins at 12 weeks of gestation.
Information presented to the committee also runs counter to the idea
that babies' bodies can't shed mercury, she said. Preliminary data from
the National Institute of Allergy and Infectious Diseases indicates that
2-month-olds promptly eliminate mercury after immunization.
McCormick is chair of the Department of Maternal and Child Health in
Harvard School of Public Health. She and many other health officials
worry about what will happen if parents grow too frightened to vaccinate
their children.
The threat posed by diseases remains very real, McCormick said, as do
the consequences of ignoring immunization recommendations. People will
become ill and some will die if they are not vaccinated.
Public health officials also discount the jump in the numbers of
children with autistic spectrum disorder and more vaccines.
The diagnosis for autism has changed drastically during the last 30
years, McCormick said. Federal laws have made educating children with
special needs more important.
People are much better informed today about disabilities, and they do a
better job of identifying children with autism spectrum disorder.
The idea that autism is increasing because of better diagnoses strikes
Cave as ridiculous and possibly disingenuous.
"If you had a child that was developing normally for 15-18 months who
lost eye contact, speech and started mutilating himself, who wouldn't
sleep, wouldn't eat and had chronic diarrhea, do you think the child
would go undiagnosed?"
My son is not an anecdote
The issue is pitting parents against pediatricians. Part of the
problem is the way scientists present their findings. The language is as
precise as possible, spelling out in detail what is known and not known.
Guessing isn't a widely admired technique in the research community.
Scientists don't base their reputations, their very credibility, not to
mention their funding, on word of mouth, on unproved anecdotal evidence
(even if the number of these anecdotes/autistic children has doubled or
tripled in the last decade and anecdotes are piling up at record pace).
Dozens and dozens of factors must be considered, tested, and accounted
for, and other researchers must be able to reproduce these results.
But a mother who divides her day by therapies -- speech, physical,
occupational, behavior modification, and all the time she puts into
repeating those lessons on her own -- a mother who may have slept only
two or three hours a night for the last two years because that's all her
baby sleeps, a mother whose child shrieks if his bare feet touch sand
because he can't stand the texture, a mother who has seen the "Hokey
Pokey," "Old MacDonald," "The Itsy Bitsy Spider" and finally even her
name, Mama, all the milestones that marked her child's growth, every
memory she holds dear wiped away, evaporated, just gone, this woman
doesn't want her experience, her child's disability (which she more than
likely believes was preventable), casually dismissed by a researcher as
an anecdote. A tale told by idiots. A sound and fury signifying nothing.
"What's worst is when they sit there and try to pacify you and say, 'I'm
really, really sorry for what happened to you, but vaccines don't cause
autism,'" Smith said. "Don't patronize me. Don't tell me that I'm crazy.
è I sat there and watched my kid slip away right underneath me."
Some things never leave you
Smith and Reynolds say will never get over the damage they believe
vaccines did to their sons.
Reminders of what her son has lost surface from time to time, Smith
said. The ball game Jacob can't attend because it's too much
stimulation. Missing the family get-together at Christmas for the same
reason.
Maybe Jacob's twin Jesse came home excited about the new sports team
he's going to join, other kids in his class and their birthday parties.
"You think, 'Gosh, I wonder if Jacob even really has someone that's his
best friend,'" Smith said. "I wonder if they're picking on him at
recess, or do they make fun of him?"
You learn to cope, she said, because there's no other choice.
So the women channel their anger and their energy into Unlocking Autism,
a national nonprofit they started to raise awareness about autism.
The duo has gathered nearly 6,000 pictures of autistic children.
Ultimately, they hope to round up 58,000 portraits, the equivalent of
one-tenth of the United States' autistic residents.
Reynolds said they hope more publicity about autism will translate into
more research dollars and more favorable laws.
Still, Smith and Reynolds consider themselves lucky.
Jacob began making eye contact and speaking in three-word sentences just
days after Cave began treating him. Jacob is now in the first grade and
doing pretty well. He eats lunch in the cafeteria with all the other
kids. He goes to P.E. and music classes. He wants to be a zookeeper.
Liam is in a class for autistic children. He is a little behind his
classmates in speech skills. But Liam talks and asks questions. It's
hard to pick him out of a crowd. And the milestones are again piling up.
A few weeks ago, Liam and his mom went to the Mall of Louisiana to watch
the circus. Liam asked for permission to sit up front, with all the
other kids. When a clown asked audience members who wanted to come out
and dance in the center of the ring, Liam volunteered.
And then Liam did something Shelley hadn't seen in four years: the Hokey
Pokey.
That's what it's all about.
*********************************************
Home
Contact Us & Upcoming
Events
Overview of
Autism
Where to Start
Florida
Agencies
National
Agencies
Treatment
Options
Vision and AIT
Vaccine
Doctors
Therapists
Respite, EI &
Governnment
Adult
Legal & School
Medical
Allergies
Books & Links
Vitamins,
Diet and Health
Misc.
Helping Hands
Abbreviations
& Definitions
Membership &
Order Form
Past ARN Newsletters
Copyright 1999 Autism Recovery Network
